§ 13F · FUND PROFILE
Stonepine Capital Management, LLC.
Institutional filer · behavioral pattern: Other. Summary pending.
AUM · $101.9T (13F)Positions · 59Turnover · — · Q4Filed · Feb 13, 2026
CONCENTRATION
—
Top 10 holdings
NEW BUYS
0
+$31.8T deployed
EXITS
0
No exits
SECTOR SHIFT
—
No prior quarter data
3YR HIT RATE
—
Top-5 overlap
§ 01 · TOP HOLDINGS
The book · Q4 2025
FILED FEB 13, 2026
| # | Ticker | Name | Shares | $ value | % port | Δ Q4 |
|---|---|---|---|---|---|---|
| 1 | VSTM | VERASTEM INC | 2.73M | $21.1T | 15.4% | +2% |
| 2 | ADMA | ADMA BIOLOGICS INC | 740K | $13.5T | 9.9% | ±0% |
| 3 | EOLS | EVOLUS INC | 1.63M | $10.9T | 7.9% | +6% |
| 4 | ZVRA | ZEVRA THERAPEUTICS INC | 569K | $5.1T | 3.7% | −30% |
| 5 | IKT | INHIBIKASE THERAPEUTICS INC | 2.35M | $4.8T | 3.5% | +219% |
| 6 | ABEO | ABEONA THERAPEUTICS INC | 710K | $3.7T | 2.7% | +57% |
| 7 | NKTR | NEKTAR THERAPEUTICS | 85K | $3.6T | 2.6% | ±0% |
| 8 | INDV | INDIVIOR PLC | 100K | $3.6T | 2.6% | ±0% |
| 9 | CRBP | CORBUS PHARMACEUTICALS HLDGS | 390K | $3.2T | 2.3% | NEW |
| 10 | KZIA | KAZIA THERAPEUTICS LTD | 460K | $3.2T | 2.3% | NEW |
§ 02 · SECTOR ALLOCATION
Where the money is
Sector data pending
§ 03 · THE STONEPINE SIGNAL
AC read
Stonepine Capital Management, LLC is a Other fund managing $101927.5 trillion in assets. The fund runs a portfolio of 59 positions.
Read the full dossier →§ 04 · FILING HISTORY
Q-by-Q deltas
1 FILINGS
Q4 2025
Steady book
+0 buys · −0 exits · 0 changed
Q3 2025
Steady book
+0 buys · −0 exits · 0 changed
Q2 2025
Steady book
+0 buys · −0 exits · 0 changed
Q1 2025
Steady book
+0 buys · −0 exits · 0 changed